Abstract:The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment.The open resource is unique in its size and scope.A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain.Follow-up information is provided by linking health and medical records.Genome-wide genotype data have been collected on all participants, providing many opportunities for the discovery of new genetic associations and the genetic bases of complex traits.Here we describe the centralized analysis of the genetic data, including genotype quality, properties of population structure and relatedness of the genetic data, and efficient phasing and genotype imputation that increases the number of testable variants to around 96 million.Classical allelic variation at 11 human leukocyte antigen genes was imputed, resulting in the recovery of signals with known associations between human leukocyte antigen alleles and many diseases.Understanding the role that genetics has in phenotypic and disease variation, and its potential interactions with other factors, is crucial for a better understanding of human biology.It is hoped that this will lead to more successful drug development 1 , and potentially to more efficient and personalized treatments.As such, a key component of the UK Biobank resource has been the collection of genome-wide genetic data on every participant using a purpose-designed genotyping array 2 .An interim release of genotype data on approximately 150,000 UK Biobank participants in May 2015 3 has already facilitated numerous studies [4][5][6] .In this paper, we summarize the existing and planned content of the phenotype resource and describe the genetic dataset on the full 500,000 participants.To facilitate its wider use, we applied a range of quality control procedures and conducted a set of analyses that reveal properties of the genetic data-such as population structure and relatedness-that can be important for downstream analyses.In addition, we estimated haplotypes and imputed genotypes into the dataset that increases the number of testable variants by more than 100-fold to approximately 96 million variants.We also imputed classical allelic variation at 11 human leukocyte antigen (HLA) genes, and replicated signals of known associations between HLA alleles and many common diseases.We describe tools that allow efficient genomewide association studies (GWAS) of multiple traits and fast phenome-wide association studies, which work together with a new compressed file format that has been used to distribute the dataset.As a further check of the genotyped and imputed datasets, we performed a test-case genome-wide association scan on a well-studied human trait, standing height.

Exome sequencing and analysis of 454,787 UK Biobank participants

Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

Analysis of protein-coding genetic variation in 60,706 humans

Efficient Identification of Trait-Associated Loss-of-function Variants in the UK Biobank Cohort by Exome-Sequencing Based Genotype Imputation

Genetic associations of protein-coding variants in human disease

Rare coding variant analysis for human diseases across biobanks and ancestries

Identifying novel genetic and phenotypic associations to genomic features by leveraging off-target reads in exome sequencing data

Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

Imputation of Exome Sequence Variants into Population- Based Samples and Blood-Cell-trait-associated Loci in African Americans: NHLBI GO Exome Sequencing Project.

High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation

Faculty Opinions Recommendation of the UK Biobank Resource with Deep Phenotyping and Genomic Data.

Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity

A deep catalogue of protein-coding variation in 983,578 individuals

Investigation of recessive effects of coding variants on common clinical phenotypes in exome-sequenced UK Biobank participants

Rare variant associations with plasma protein levels in the UK Biobank

Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation